Detalhe da pesquisa
1.
Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy.
Clin Endocrinol (Oxf)
; 85(1): 137-49, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26589105
2.
Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies.
Proc Natl Acad Sci U S A
; 105(20): 7257-62, 2008 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18458326
3.
Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms.
Endocrinology
; 149(11): 5679-87, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18669592
4.
Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats.
Obesity (Silver Spring)
; 18(1): 21-6, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19543217
5.
Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy.
Obesity (Silver Spring)
; 17(9): 1736-43, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19521351
6.
Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patients.
Radiology
; 230(1): 287-93, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14695402